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Background
Asthma is a chronic condition described by inflammation
of the airways and lungs. Diesel exhaust (DE) is a major
contributor to ambient particulate matter (PM) air pollu-
tion. There is rising evidence that PM acts as adjuvant on
the immune responses and may lead to augmentation of
allergic inflammation [1,2]. We aim to elucidate if DE
increases allergen-induced inflammation and cellular
immune response in the airways of atopic human subjects.
Methods
15 volunteer participants with allergy to house dust mite
allergen (Der p 1), birch or Timothy grass were
recruited. In a randomized fashion, subjects inhaled DE
(300µg PM2.5/m
3) or filtered air for 120 minutes. One
hour following the exposure, the extract of an aeroaller-
gen to which the individual is sensitive, or placebo (ster-
ile saline), was instilled into contralateral lung segments
through bronchoscopy. Endobronchial biopsies from
these same segments were then acquired 48 hours after
each exposure. This was repeated 4 weeks later in each
subject with the alternative inhalant. Thus, biopsies
under 4 different conditions were created: filtered air +
saline (FAS), DE + saline (DES), filtered air + allergen
(FAA) and DE + allergen (DEA). Biopsies were pro-
cessed and embedded in glycol methanlacrylate acrylic
resin and serial sections were cut to 2µm and used for
immunostaining with monoclonal antibodies to tryptase
and eosinophil cationic protein (ECP). The percent posi-
tivity and distribution of activated mast cells (tryptase+)
and eosinophils (ECP+) were quantified in the bronchial
submucosa by Aperio ImageScope software.
Results
The percent positivity for tryptase expression: FAS=0.54
±0.05, DES=0.51±0.18, FAA=0.63±0.24, DEA= 0.94±0.23.
The percent positivity for ECP expression: FAS=0.35±0.17,
DES=0.38±0.11, FAA=0.61±0.14, DEA=0.73±0.33. Data
are presented as mean ± SEM (n=6).
Conclusions
Our preliminary data suggest that DE may enhance the
inflammatory response to allergen in atopic individuals.
This data is novel in the context of human lung tissue.
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